Oncology Learning Network

Escolta'l a la teva aplicació

• Podcast Index
• RSS

Episodis

191 episodis

1. Artificial Intelligence Advances Lymphoma Diagnosis, Biomarker Identification, and Precision Treatment fa 6 dies 5:17
2. Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice fa 1 mes 10:57
3. Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice fa 1 mes 12:28
4. Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice fa 2 mesos 13:58
5. Preparing for Biomarker-Directed Care in epNEC: What Pathologists Need to Know Now fa 3 mesos 12:28
6. Artificial Intelligence for Skin Cancer Diagnosis fa 3 mesos 11:57
7. Beyond FVC: What FIBRONEER-ILD Means for Outcomes, Patients, and Access in PPF fa 4 mesos 17:10
8. Real-World Decision Points in Biomarker-Driven NSCLC Management fa 4 mesos 5:17
9. Connecting the Dots: How MET Fits Into Comprehensive Molecular Profiling fa 4 mesos 3:56
10. Testing Matters: Practical Approaches to Biomarker Evaluation in NSCLC fa 4 mesos 6:47
11. Tafasitamab Plus Lenalidomide Improves Frontline Outcomes in High-Risk Diffuse Large B-Cell Lymphoma fa 4 mesos 6:30
12. When to Raise the Question of CAR T–Cell Therapy in Multiple Myeloma fa 5 mesos 8:50
13. Closing the Gap Between CAR T–Cell Therapy Recognition and Referral in Multiple Myeloma fa 5 mesos 13:03
14. Olverembatinib Plus Blinatumomab Produces Deep Responses in Ph+ Acute Lymphoblastic Leukemia fa 5 mesos 3:44
15. How is ctDNA MRD Testing Used in Lymphoma Care? fa 5 mesos 9:11
16. How Are We Detecting Residual Disease in Lymphoma Today? fa 5 mesos 8:48
17. How Are We Detecting Residual Disease in Lymphoma Today? fa 5 mesos 8:59
18. Treatment of Recurrent Refractory Pediatric Low-Grade Glioma (pLGG) fa 1 any 8:55
19. Navigating The Complexity of Melanoma Care: Part 6 fa 1 any 2:01
20. Navigating The Complexity of Melanoma Care: Part 5 fa 1 any 1:35
21. Navigating The Complexity of Melanoma Care: Part 4 fa 1 any 2:40
22. Navigating The Complexity of Melanoma Care: Part 3 fa 1 any 1:15
23. Navigating The Complexity of Melanoma Care: Part 2 fa 1 any 2:16
24. Navigating The Complexity of Melanoma Care: Part 1 fa 1 any 2:46
25. Community Education Program Improves Patient Education and Cancer Screening Rates fa 1 any 7:01
26. Cholangioscopy: What Interventional Oncologists Need to Know Part 2 fa 2 anys 46:05
27. Cholangioscopy: What Interventional Oncologists Need to Know fa 2 anys 41:01
28. Applications of AR in Interventional Oncology fa 2 anys 11:45
29. How Artificial Intelligence May Change Interventional Oncology fa 3 anys 26:30
30. Sacituzumab Govitecan Plus Pembrolizumab in the TROPHY-U-01 Trial fa 3 anys 7:31
31. Episode 1: Maintenance Rituximab for Waldenström Macroglobulinemia fa 3 anys 26:10
32. Neoadjuvant Chemotherapy Plus HER2-Targeted Therapy for Early Stage HER2-Positive Breast Cancer fa 4 anys 7:17
33. Advances in Gastrointestinal Genetic Testing fa 4 anys 4:51
34. Enfortumab Vedotin for Metastatic Urothelial Cancer After Progression on Platinum-Based Chemotherapy fa 4 anys 6:58
35. BRCAness May Predict Response to Platinum-Based Chemotherapy in Intrahepatic Cholangiocarcinoma fa 4 anys 7:33
36. Durvalumab Conveys Benefit for All Biliary Tract Cancer Types fa 4 anys 5:29
37. Pemigatinib for Cholangiocarcinoma with FGFR2 Fusions or Rearrangements fa 4 anys 4:32
38. Maintenance Cabozantinib in Metastatic Urothelial Carcinoma fa 4 anys 4:51
39. Sacituzumab Govitecan Plus Pembrolizumab for Platinum-Refractory Metastatic Urothelial Cancer fa 4 anys 8:45
40. Part 2: Overcoming PARP Inhibitor and Platinum Resistance in Patients With Ovarian Cancer fa 4 anys 7:06
41. Part 1: Current Emerging Therapies for Platinum-Resistant Ovarian Malignancies With Dr O'Mally fa 4 anys 9:48
42. Therapeutic Advances and Considerations for Treatment Selection in High-Risk AML fa 5 anys 25:00
43. Ibrutinib Improves Outcomes Over Rituximab Among Patients With Advanced CLL/SLL fa 5 anys 8:40
44. Evolving Roles of KRAS Inhibitors in CRC fa 5 anys 1:45
45. The Role of Tumor Mutation Burden Featuring Dr Morris fa 5 anys 0:50
46. Dr Morris Discusses Emerging Targeted Therapies in mCRC fa 5 anys 3:02
47. Dr Lieu Talks ctDNA to Guide CRC Treatment fa 5 anys 3:15
48. Dr Casulo Overviews Approved Treatment Options to Manage Newly Diagnosed, Relapsed FL fa 5 anys 5:20
49. Dr Batlevi Shares Promising Data of Tazemetostat from SYMPHONY-1 Trial fa 5 anys 4:46
50. Dr Loprinzi Reviews Hot Flash Treatment Strategies in BC, Part II fa 5 anys 0:19